POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL

POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL was reported 1134 times

POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYCOTIC CORNEAL ULCER 2 0.2500
1 CONJUNCTIVITIS FUNGAL 1 0.2500
2 CONTAMINATED PRODUCT ADMINISTERED 7 0.1148
3 HYPERTENSIVE ANGIOPATHY 3 0.0667
4 BOWEL PREPARATION 1 0.0667
5 PRODUCT CONTAMINATION MICROBIAL 61 0.0511
6 CONJUNCTIVAL PAPILLAE 1 0.0500
7 TEAR DISCOLOURATION 2 0.0444
8 FOREIGN BODY SENSATION IN EYES 257 0.0403
9 EYELASH HYPERPIGMENTATION 2 0.0400
10 ASTHENOPIA 193 0.0351
11 BLEPHAROPACHYNSIS 1 0.0323
12 BLOOD BILIRUBIN UNCONJUGATED DECREASED 1 0.0278
13 EYE NAEVUS 3 0.0263
14 PRODUCT DROPPER ISSUE 20 0.0254
15 ACQUIRED ATTR AMYLOIDOSIS 1 0.0244
16 SCLERAL HYPERAEMIA 14 0.0206
17 CHEMICAL EYE INJURY 2 0.0204
18 ARTERIAL STENOSIS LIMB 1 0.0196
19 CORNEAL EXFOLIATION 2 0.0196
20 SUPERFICIAL INJURY OF EYE 21 0.0192
21 PINGUECULA 2 0.0189
22 SWOLLEN TEAR DUCT 2 0.0189
23 EYELASH DISCOLOURATION 4 0.0183
24 EYE INFECTION FUNGAL 7 0.0181
25 EYELID MARGIN CRUSTING 50 0.0173
26 CORNEAL ULCER 1 0.0172
27 EYE DISCHARGE 179 0.0172
28 EYELID INJURY 3 0.0170
29 HYPOAESTHESIA EYE 10 0.0169
30 EYE IRRITATION 966 0.0168
31 EYELASH THICKENING 2 0.0167
32 EPIRETINAL MEMBRANE 4 0.0144
33 INSTILLATION SITE FOREIGN BODY SENSATION 2 0.0138
34 ABNORMAL SENSATION IN EYE 59 0.0137
35 BRAIN RADIATION NECROSIS 1 0.0135
36 CORNEAL IRRITATION 1 0.0125
37 EYELASH CHANGES 2 0.0113
38 COELIAC ARTERY STENOSIS 1 0.0110
39 PRESBYOPIA 6 0.0108
40 CILIARY HYPERAEMIA 1 0.0105
41 CORNEAL CYST 1 0.0103
42 RETINOPATHY HYPERTENSIVE 3 0.0099
43 KERATITIS FUNGAL 2 0.0096
44 CORNEAL INFILTRATES 3 0.0096
45 CORNEAL GRAFT REJECTION 2 0.0095
46 OPTIC DISC DISORDER 2 0.0095
47 EYE PRURITUS 319 0.0095
48 EXPOSURE TO FUNGUS 2 0.0093
49 SCLERAL DISCOLOURATION 6 0.0091
50 ERYTHEMA OF EYELID 49 0.0090
51 INSTILLATION SITE PAIN 22 0.0089
52 EYELID EXFOLIATION 7 0.0089
53 CHOROID MELANOMA 1 0.0088
54 SEPTIC ARTHRITIS STAPHYLOCOCCAL 3 0.0086
55 OCULAR HYPERAEMIA 409 0.0086
56 EYE ALLERGY 13 0.0084
57 EYELID IRRITATION 21 0.0084
58 EYELIDS PRURITUS 26 0.0083
59 EYE PAIN 461 0.0082
60 CORNEAL SCAR 4 0.0080
61 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
62 DRY EYE 393 0.0079
63 GLAUCOMA SURGERY 2 0.0078
64 PUNCTATE KERATITIS 7 0.0076
65 CORNEAL DEFECT 1 0.0076
66 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
67 ARTERIOVENOUS FISTULA OPERATION 2 0.0074
68 CUTIS LAXA 2 0.0074
69 CHEMICAL BURNS OF EYE 2 0.0072
70 PRODUCT DESIGN ISSUE 5 0.0070
71 DACRYOSTENOSIS ACQUIRED 9 0.0070
72 EYE ULCER 4 0.0069
73 PERIORBITAL CONTUSION 2 0.0069
74 PRODUCT ODOUR ABNORMAL 71 0.0068
75 PRODUCT WITH QUALITY ISSUE ADMINISTERED 3 0.0067
76 PRODUCT PACKAGE ASSOCIATED INJURY 15 0.0067
77 CONJUNCTIVAL SCAR 1 0.0066
78 CORNEAL ABRASION 9 0.0066
79 VISUAL ACUITY REDUCED TRANSIENTLY 2 0.0065
80 CORNEAL LESION 2 0.0065
81 LACRIMATION INCREASED 192 0.0063
82 TRICHIASIS 2 0.0063
83 BREAST DISCOLOURATION 1 0.0063
84 REACTION TO PRESERVATIVES 5 0.0061
85 BLEPHARAL PIGMENTATION 3 0.0059
86 PERIORBITAL PAIN 5 0.0059
87 CHOROIDAL NEOVASCULARISATION 5 0.0058
88 OCULAR DISCOMFORT 65 0.0058
89 DISCHARGE 8 0.0058
90 KERATOPATHY 9 0.0057
91 IRIS DISORDER 3 0.0056
92 CORNEAL EROSION 3 0.0056
93 ARTHROPOD STING 9 0.0054
94 KERATOCONUS 2 0.0053
95 CHEST TUBE INSERTION 1 0.0053
96 CONJUNCTIVAL DISORDER 2 0.0052
97 FOREIGN BODY IN EYE 5 0.0052
98 HYPOPYON 4 0.0048
99 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
100 BLOOD SODIUM ABNORMAL 5 0.0047
101 CHORIORETINITIS 3 0.0047
102 NASAL CRUSTING 3 0.0046
103 KLEBSIELLA TEST POSITIVE 3 0.0046
104 VISION BLURRED 632 0.0046
105 SEXUALLY TRANSMITTED DISEASE 2 0.0046
106 LENTICULAR OPACITIES 2 0.0046
107 INCISIONAL DRAINAGE 2 0.0046
108 EYELID PAIN 9 0.0044
109 EYELID DISORDER 10 0.0043
110 EYELID SKIN DRYNESS 5 0.0041
111 CORNEAL DISORDER 9 0.0041
112 CORNEAL NEOVASCULARISATION 1 0.0040
113 CORNEAL DEPOSITS 3 0.0040
114 ULCERATIVE KERATITIS 11 0.0040
115 MEDICATION RESIDUE PRESENT 19 0.0040
116 SUSPECTED PRODUCT CONTAMINATION 4 0.0039
117 EYE COLOUR CHANGE 4 0.0039
118 PRODUCT CLOSURE REMOVAL DIFFICULT 4 0.0039
119 INSTILLATION SITE ERYTHEMA 2 0.0038
120 GROWTH OF EYELASHES 3 0.0038
121 DEPOSIT EYE 1 0.0037
122 COOMBS TEST POSITIVE 1 0.0037
123 CORNEAL OPACITY 5 0.0037
124 EYE INFECTION BACTERIAL 2 0.0036
125 OPHTHALMIC HERPES SIMPLEX 2 0.0035
126 OPTIC NERVE INJURY 4 0.0034
127 SJOGREN'S SYNDROME 2 0.0034
128 EYE LASER SURGERY 2 0.0034
129 EXCESSIVE EYE BLINKING 5 0.0034
130 INSTILLATION SITE IRRITATION 4 0.0034
131 EYE INFECTION 38 0.0034
132 SWELLING OF EYELID 21 0.0033
133 ASTIGMATISM 5 0.0033
134 ANALGESIC THERAPY 1 0.0031
135 CONDUCTIVE DEAFNESS 1 0.0031
136 EYELID OEDEMA 36 0.0031
137 OCULAR HYPERTENSION 6 0.0031
138 EYELID RASH 3 0.0031
139 PERSONALITY DISORDER 8 0.0031
140 EYE INFLAMMATION 29 0.0030
141 CATARACT NUCLEAR 2 0.0030
142 BLEPHARITIS 12 0.0030
143 MACULAR FIBROSIS 2 0.0029
144 CONJUNCTIVITIS BACTERIAL 1 0.0029
145 OPHTHALMIC MIGRAINE 2 0.0029
146 LIQUID PRODUCT PHYSICAL ISSUE 21 0.0029
147 EYE SWELLING 106 0.0028
148 INSTILLATION SITE REACTION 3 0.0028
149 METAMORPHOPSIA 5 0.0027
150 ESSENTIAL TREMOR 3 0.0027
151 PRODUCT CONTAINER ISSUE 23 0.0027
152 RETINAL OEDEMA 5 0.0026
153 APPENDICOLITH 1 0.0026
154 CORNEAL TRANSPLANT 2 0.0026
155 RETINAL VASCULITIS 3 0.0025
156 BLADDER PROLAPSE 3 0.0025
157 CORNEAL DYSTROPHY 1 0.0024
158 PHOTOPHOBIA 45 0.0024
159 ALVEOLAR OSTEITIS 1 0.0024
160 INTRAOCULAR PRESSURE INCREASED 30 0.0023
161 HORDEOLUM 10 0.0023
162 VITREOUS DETACHMENT 5 0.0023
163 POOR QUALITY PRODUCT ADMINISTERED 24 0.0023
164 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
165 ALLERGY TO PLANTS 1 0.0022
166 PRODUCT PHYSICAL CONSISTENCY ISSUE 12 0.0022
167 EXPIRED PRODUCT ADMINISTERED 72 0.0022
168 VITRITIS 4 0.0022
169 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 3 0.0021
170 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
171 BLADDER MASS 1 0.0020
172 KERATITIS 6 0.0020
173 CONJUNCTIVAL OEDEMA 2 0.0019
174 RETINAL DISORDER 5 0.0019
175 NIGHT BLINDNESS 3 0.0019
176 PRODUCT QUALITY ISSUE 251 0.0018
177 MADAROSIS 21 0.0018
178 PRODUCT PACKAGING ISSUE 17 0.0018
179 CORNEAL OEDEMA 4 0.0018
180 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
181 HALO VISION 2 0.0018
182 INCORRECT STORAGE OF DRUG 3 0.0017
183 LUMBAR RADICULOPATHY 2 0.0017
184 AORTIC CALCIFICATION 1 0.0017
185 AMBLYOPIA 1 0.0017
186 EYE INJURY 5 0.0016
187 OTITIS EXTERNA 2 0.0016
188 BLOOD BILIRUBIN DECREASED 1 0.0016
189 AORTIC VALVE REPLACEMENT 2 0.0016
190 CORNEAL PERFORATION 1 0.0016
191 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
192 PRODUCT COLOUR ISSUE 8 0.0016
193 RETINAL DEGENERATION 2 0.0015
194 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
195 BLINDNESS TRANSIENT 11 0.0015
196 SKIN WRINKLING 4 0.0015
197 VITREOUS FLOATERS 14 0.0014
198 BLOOD OESTROGEN DECREASED 1 0.0014
199 CONJUNCTIVAL HYPERAEMIA 5 0.0014
200 CERVICAL RADICULOPATHY 1 0.0014
201 BACTERIAL DISEASE CARRIER 1 0.0014
202 DARK CIRCLES UNDER EYES 2 0.0014
203 EYE HAEMORRHAGE 18 0.0013
204 AXILLARY PAIN 2 0.0013
205 BRONCHITIS BACTERIAL 1 0.0013
206 AGE-RELATED MACULAR DEGENERATION 2 0.0013
207 DEBRIDEMENT 1 0.0013
208 GLAUCOMA 25 0.0013
209 SEASONAL ALLERGY 18 0.0013
210 CHOROIDAL EFFUSION 1 0.0012
211 BARRETT'S OESOPHAGUS 1 0.0012
212 CONJUNCTIVITIS 23 0.0012
213 VISUAL ACUITY REDUCED 41 0.0012
214 EYE DISORDER 40 0.0012
215 COLLAPSE OF LUNG 1 0.0012
216 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
217 VASODILATATION 3 0.0012
218 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
219 GLIOBLASTOMA 2 0.0012
220 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
221 OTORRHOEA 2 0.0011
222 INFUSION SITE DISCHARGE 2 0.0011
223 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
224 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
225 ABDOMINAL NEOPLASM 1 0.0011
226 BLEPHAROSPASM 7 0.0011
227 CATARRH 1 0.0011
228 CERUMEN IMPACTION 1 0.0011
229 BONE GRAFT 1 0.0011
230 ACTINOMYCOSIS 1 0.0010
231 PRODUCT LABEL ISSUE 7 0.0010
232 VOCAL CORD DISORDER 2 0.0010
233 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
234 BLADDER CANCER RECURRENT 1 0.0010
235 FIBROSIS 3 0.0010
236 CATARACT 58 0.0010
237 BREAST NEOPLASM 1 0.0010
238 CYST 12 0.0010
239 IRIDOCYCLITIS 3 0.0009
240 PHOTOPSIA 6 0.0009
241 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
242 PRODUCT RESIDUE PRESENT 5 0.0009
243 ACARODERMATITIS 1 0.0009
244 PRODUCT FORMULATION ISSUE 6 0.0009
245 PRODUCT LOT NUMBER ISSUE 2 0.0009
246 COMPLEX PARTIAL SEIZURES 1 0.0009
247 LYME DISEASE 3 0.0009
248 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
249 EYELID PTOSIS 9 0.0009
250 PERIORBITAL SWELLING 5 0.0009
251 NASAL DISCOMFORT 7 0.0009
252 SECRETION DISCHARGE 11 0.0009
253 HAEMATOCRIT INCREASED 2 0.0009
254 CORTISOL DECREASED 1 0.0009
255 RETINAL DETACHMENT 8 0.0009
256 VISUAL IMPAIRMENT 107 0.0009
257 HYPOAESTHESIA ORAL 13 0.0009
258 EAR PRURITUS 3 0.0009
259 SKIN TIGHTNESS 4 0.0008
260 FACIAL PARESIS 3 0.0008
261 MACULOPATHY 3 0.0008
262 RETINAL HAEMORRHAGE 6 0.0008
263 CHRONIC RESPIRATORY FAILURE 1 0.0008
264 BREATH ODOUR 2 0.0008
265 EXPIRED DRUG ADMINISTERED 4 0.0008
266 BLOOD UREA DECREASED 1 0.0008
267 BLADDER DISCOMFORT 1 0.0008
268 NASAL DRYNESS 5 0.0008
269 EXCORIATION 2 0.0008
270 DRY THROAT 8 0.0008
271 OESOPHAGEAL DISORDER 3 0.0008
272 INCREASED UPPER AIRWAY SECRETION 4 0.0008
273 POOR QUALITY DRUG ADMINISTERED 5 0.0008
274 PERIORBITAL OEDEMA 4 0.0008
275 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
276 ANAEMIA POSTOPERATIVE 1 0.0008
277 BLOOD POTASSIUM ABNORMAL 2 0.0007
278 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
279 FLANK PAIN 7 0.0007
280 BREAST SWELLING 2 0.0007
281 RHINALGIA 2 0.0007
282 LYMPHOEDEMA 5 0.0007
283 CARDIOVERSION 1 0.0007
284 DRUG TOLERANCE DECREASED 2 0.0007
285 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
286 PRODUCT DISPENSING ISSUE 3 0.0007
287 LUNG CANCER METASTATIC 2 0.0007
288 TASTE DISORDER 14 0.0007
289 IMMUNE SYSTEM DISORDER 9 0.0007
290 STRABISMUS 2 0.0007
291 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
292 CONJUNCTIVITIS ALLERGIC 1 0.0007
293 FACIAL PAIN 6 0.0007
294 IRON DEFICIENCY 3 0.0007
295 ADHESION 1 0.0007
296 IRITIS 2 0.0007
297 ROSACEA 3 0.0006
298 BACTERIAL VAGINOSIS 1 0.0006
299 BLINDNESS UNILATERAL 9 0.0006
300 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23 0.0006
301 LIMB OPERATION 3 0.0006
302 MYDRIASIS 8 0.0006
303 CYSTITIS INTERSTITIAL 1 0.0006
304 DIPLOPIA 16 0.0006
305 COSTOCHONDRITIS 1 0.0006
306 OEDEMA MOUTH 2 0.0006
307 OTITIS MEDIA 2 0.0006
308 MACULAR DEGENERATION 7 0.0006
309 BLADDER NEOPLASM 1 0.0006
310 BLOOD AMYLASE INCREASED 1 0.0006
311 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
312 AMYLOIDOSIS 1 0.0006
313 GROIN PAIN 5 0.0006
314 AORTIC VALVE STENOSIS 1 0.0006
315 WOUND HAEMORRHAGE 2 0.0005
316 ARTHROPOD BITE 4 0.0005
317 BLOOD CHOLESTEROL DECREASED 1 0.0005
318 AURA 1 0.0005
319 FACE INJURY 2 0.0005
320 RECALLED PRODUCT ADMINISTERED 5 0.0005
321 CONVERSION DISORDER 1 0.0005
322 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
323 EPIGASTRIC DISCOMFORT 2 0.0005
324 ORAL INFECTION 2 0.0005
325 WOUND SECRETION 2 0.0005
326 CATARACT OPERATION 3 0.0005
327 BLADDER DISORDER 5 0.0005
328 RHINITIS 4 0.0005
329 POST PROCEDURAL INFECTION 4 0.0005
330 PERIPHERAL VENOUS DISEASE 2 0.0005
331 PARAESTHESIA ORAL 7 0.0005
332 PHOTOSENSITIVITY REACTION 8 0.0005
333 TENDERNESS 5 0.0005
334 TONGUE DISCOMFORT 2 0.0005
335 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
336 ENTERITIS 3 0.0005
337 CATHETER SITE ERYTHEMA 1 0.0005
338 TENSION HEADACHE 2 0.0005
339 ABSCESS INTESTINAL 1 0.0005
340 CERVICAL DYSPLASIA 1 0.0005
341 ONYCHOMYCOSIS 2 0.0005
342 DYSGRAPHIA 3 0.0005
343 PARONYCHIA 2 0.0005
344 SINUS DISORDER 9 0.0005
345 GINGIVAL SWELLING 2 0.0005
346 RHINITIS ALLERGIC 2 0.0004
347 WRONG DRUG ADMINISTERED 4 0.0004
348 APPLICATION SITE URTICARIA 1 0.0004
349 PRODUCT ADMINISTRATION ERROR 9 0.0004
350 BRONCHIECTASIS 3 0.0004
351 SINUS CONGESTION 6 0.0004
352 PELVIC PAIN 8 0.0004
353 OPTIC NEURITIS 4 0.0004
354 BRAIN NEOPLASM 4 0.0004
355 EYE OPERATION 2 0.0004
356 NERVE COMPRESSION 4 0.0004
357 SYNOVIAL CYST 2 0.0004
358 MASS 6 0.0004
359 SPUTUM DISCOLOURED 4 0.0004
360 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
361 FAECAL INCONTINENCE 2 0.0004
362 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
363 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
364 HYPERVOLAEMIA 2 0.0004
365 LIGAMENT SPRAIN 4 0.0004
366 DIABETIC NEUROPATHY 2 0.0004
367 INFLAMMATORY MARKER INCREASED 2 0.0004
368 HEART RATE IRREGULAR 9 0.0004
369 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
370 ANGLE CLOSURE GLAUCOMA 1 0.0004
371 RENAL FAILURE CHRONIC 3 0.0004
372 EAR DISCOMFORT 4 0.0004
373 FOOD ALLERGY 3 0.0004
374 BLOOD CHLORIDE DECREASED 1 0.0004
375 TOOTHACHE 7 0.0004
376 ACTINIC KERATOSIS 1 0.0004
377 MULTIPLE ALLERGIES 3 0.0004
378 ANIMAL BITE 1 0.0004
379 NASAL CONGESTION 22 0.0004
380 BODY HEIGHT DECREASED 4 0.0004
381 INTESTINAL RESECTION 2 0.0004
382 BRUXISM 2 0.0004
383 FIBROMYALGIA 9 0.0004
384 FOOT FRACTURE 7 0.0004
385 DECUBITUS ULCER 3 0.0004
386 ENCEPHALOPATHY 9 0.0004
387 BLOOD PHOSPHORUS INCREASED 1 0.0004
388 ABNORMAL FAECES 3 0.0004
389 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
390 DEAFNESS UNILATERAL 2 0.0004
391 TOOTH FRACTURE 4 0.0004
392 HYPERKERATOSIS 2 0.0004
393 DENTAL CARIES 4 0.0004
394 SNEEZING 8 0.0004
395 SENSATION OF FOREIGN BODY 3 0.0004
396 ATYPICAL FEMUR FRACTURE 1 0.0004
397 HYPERSENSITIVITY 65 0.0003
398 SKIN HYPERPIGMENTATION 3 0.0003
399 BLOOD URIC ACID INCREASED 2 0.0003
400 LOCAL SWELLING 6 0.0003
401 PRODUCT LABEL CONFUSION 2 0.0003
402 SPINAL PAIN 4 0.0003
403 URINARY INCONTINENCE 10 0.0003
404 SINUS HEADACHE 2 0.0003
405 SYMPTOM RECURRENCE 2 0.0003
406 HEARING IMPAIRED 2 0.0003
407 OROPHARYNGEAL DISCOMFORT 3 0.0003
408 HYPOACUSIS 14 0.0003
409 RHINORRHOEA 21 0.0003
410 DYSGEUSIA 24 0.0003
411 SWELLING FACE 21 0.0003
412 NECK PAIN 18 0.0003
413 DRUG INEFFECTIVE 424 0.0003
414 EPISTAXIS 24 0.0003
415 BASAL CELL CARCINOMA 5 0.0003
416 BLOOD CREATININE DECREASED 1 0.0003
417 PRODUCT USE COMPLAINT 5 0.0003
418 SPINAL DISORDER 3 0.0003
419 THERAPEUTIC RESPONSE CHANGED 2 0.0003
420 EAR PAIN 6 0.0003
421 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
422 ANGINA UNSTABLE 2 0.0003
423 BODY TEMPERATURE DECREASED 3 0.0003
424 INCORRECT PRODUCT STORAGE 4 0.0003
425 DEAFNESS NEUROSENSORY 1 0.0003
426 EAR INFECTION 8 0.0003
427 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
428 PRODUCT TASTE ABNORMAL 4 0.0003
429 B-CELL LYMPHOMA 1 0.0003
430 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
431 POOR VENOUS ACCESS 3 0.0003
432 THROAT IRRITATION 13 0.0003
433 BLOOD CREATININE ABNORMAL 1 0.0003
434 NIGHTMARE 10 0.0003
435 HAIR GROWTH ABNORMAL 2 0.0003
436 CAROTID ARTERY STENOSIS 1 0.0003
437 LIVER INJURY 7 0.0003
438 BRONCHIOLITIS 1 0.0003
439 RENAL PAIN 3 0.0003
440 TINNITUS 13 0.0003
441 HEAD DISCOMFORT 5 0.0003
442 ERYTHEMA 58 0.0003
443 THERMAL BURN 2 0.0003
444 EATING DISORDER 6 0.0003
445 APPENDICECTOMY 1 0.0003
446 RENAL DISORDER 13 0.0003
447 BONE LESION 1 0.0003
448 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
449 VISUAL FIELD DEFECT 2 0.0003
450 TONGUE DISORDER 2 0.0003
451 DRY MOUTH 22 0.0003
452 HYPOPHOSPHATAEMIA 2 0.0003
453 OROPHARYNGEAL PAIN 25 0.0003
454 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
455 FEELING DRUNK 2 0.0003
456 COLON CANCER 4 0.0003
457 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
458 SKIN INFECTION 3 0.0003
459 CHRONIC SINUSITIS 1 0.0003
460 THERAPEUTIC RESPONSE DECREASED 16 0.0003
461 LIMB INJURY 7 0.0003
462 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
463 HAEMORRHAGIC STROKE 2 0.0003
464 CERVIX CARCINOMA 1 0.0003
465 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
466 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
467 DYSPEPSIA 25 0.0003
468 BLOOD ALBUMIN DECREASED 2 0.0003
469 GINGIVAL PAIN 2 0.0003
470 ACCIDENT 3 0.0003
471 CEREBRAL ATROPHY 1 0.0003
472 DEMENTIA 7 0.0003
473 MYASTHENIA GRAVIS 2 0.0002
474 FRUSTRATION TOLERANCE DECREASED 2 0.0002
475 HYPERAESTHESIA 2 0.0002
476 APPLICATION SITE EXFOLIATION 1 0.0002
477 HAIR DISORDER 2 0.0002
478 ACCIDENTAL EXPOSURE 1 0.0002
479 EOSINOPHIL COUNT INCREASED 2 0.0002
480 DYSPHONIA 14 0.0002
481 HALLUCINATION, VISUAL 5 0.0002
482 ABSCESS LIMB 1 0.0002
483 JOINT INJURY 5 0.0002
484 HYSTERECTOMY 2 0.0002
485 PALPITATIONS 27 0.0002
486 NAIL DISORDER 2 0.0002
487 DRUG ADMINISTRATION ERROR 7 0.0002
488 SPINAL OSTEOARTHRITIS 2 0.0002
489 ADVERSE REACTION 3 0.0002
490 THROAT TIGHTNESS 6 0.0002
491 RASH PRURITIC 12 0.0002
492 UVEITIS 3 0.0002
493 BLINDNESS 9 0.0002
494 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
495 PERIPHERAL COLDNESS 3 0.0002
496 SKIN DISCOLOURATION 10 0.0002
497 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
498 BLOOD GLUCOSE ABNORMAL 4 0.0002
499 ARTHRITIS INFECTIVE 1 0.0002
500 BACTERIAL INFECTION 4 0.0002
501 CARPAL TUNNEL SYNDROME 3 0.0002
502 BURNING SENSATION 15 0.0002
503 LACERATION 2 0.0002
504 SQUAMOUS CELL CARCINOMA 2 0.0002
505 DYSPNOEA EXERTIONAL 8 0.0002
506 OSTEOARTHRITIS 9 0.0002
507 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 43 0.0002
508 PAIN IN JAW 6 0.0002
509 CARDIAC TAMPONADE 1 0.0002
510 MUSCULOSKELETAL DISORDER 4 0.0002
511 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
512 PULMONARY FIBROSIS 4 0.0002
513 ATELECTASIS 2 0.0002
514 DIZZINESS POSTURAL 2 0.0002
515 FLUID OVERLOAD 3 0.0002
516 APATHY 3 0.0002
517 SKIN FISSURES 4 0.0002
518 BREATH SOUNDS ABNORMAL 1 0.0002
519 SKIN HAEMORRHAGE 3 0.0002
520 ABDOMINAL TENDERNESS 1 0.0002
521 UPPER LIMB FRACTURE 4 0.0002
522 APPLICATION SITE SWELLING 1 0.0002
523 AGEUSIA 5 0.0002
524 PNEUMONIA ASPIRATION 5 0.0002
525 OVARIAN CYST 2 0.0002
526 BRAIN INJURY 2 0.0002
527 CORONARY ARTERY STENOSIS 1 0.0002
528 INCORRECT DOSE ADMINISTERED 45 0.0002
529 VERTIGO 12 0.0002
530 SKIN IRRITATION 9 0.0002
531 DRUG DISPENSING ERROR 3 0.0002
532 HIP ARTHROPLASTY 3 0.0002
533 SKIN BURNING SENSATION 14 0.0002
534 SINUSITIS 20 0.0002
535 PHARYNGEAL OEDEMA 3 0.0002
536 INITIAL INSOMNIA 2 0.0002
537 DRY SKIN 26 0.0002
538 ANKLE FRACTURE 3 0.0002
539 TENDONITIS 3 0.0002
540 FEMUR FRACTURE 6 0.0002
541 RASH GENERALISED 5 0.0002
542 NERVOUS SYSTEM DISORDER 6 0.0002
543 PULMONARY HYPERTENSION 4 0.0002
544 HEADACHE 120 0.0002
545 GASTRITIS 5 0.0002
546 KNEE ARTHROPLASTY 4 0.0002
547 MOUTH ULCERATION 4 0.0002
548 SKIN EXFOLIATION 16 0.0002
549 HEAD INJURY 6 0.0002
550 ADVERSE DRUG REACTION 17 0.0002
551 BONE PAIN 11 0.0002
552 COMPRESSION FRACTURE 1 0.0002
553 CHEILITIS 1 0.0002
554 BIPOLAR DISORDER 2 0.0002
555 BACK INJURY 2 0.0002
556 BLOOD PRESSURE INCREASED 28 0.0002
557 SKIN LESION 5 0.0002
558 PERIPHERAL SWELLING 28 0.0002
559 URINARY TRACT INFECTION 31 0.0002
560 AUTISM SPECTRUM DISORDER 1 0.0002
561 APPLICATION SITE PAIN 4 0.0002
562 INFUSION RELATED REACTION 12 0.0002
563 NERVE INJURY 2 0.0002
564 ARTHRITIS 14 0.0002
565 PANCREATITIS ACUTE 4 0.0002
566 FISTULA 2 0.0002
567 MYOCARDIAL ISCHAEMIA 2 0.0002
568 SCAB 2 0.0002
569 FEELING ABNORMAL 42 0.0002
570 MICTURITION URGENCY 2 0.0002
571 CARDIAC VALVE DISEASE 1 0.0002
572 BALANCE DISORDER 15 0.0002
573 DIZZINESS 86 0.0002
574 DEVICE USE ISSUE 3 0.0002
575 PANCREATITIS 9 0.0002
576 BACTERAEMIA 2 0.0002
577 POLYNEUROPATHY 2 0.0002
578 GASTROENTERITIS VIRAL 3 0.0002
579 CHEST DISCOMFORT 17 0.0002
580 LOCALISED INFECTION 4 0.0002
581 NOCTURIA 2 0.0002
582 NEURALGIA 4 0.0002
583 DERMATITIS ACNEIFORM 1 0.0002
584 PRURITUS 63 0.0002
585 ABDOMINAL DISTENSION 17 0.0002
586 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
587 HEPATIC STEATOSIS 3 0.0002
588 TOOTH EXTRACTION 2 0.0002
589 PAIN IN EXTREMITY 47 0.0002
590 FRACTURE 3 0.0002
591 BLOOD URINE PRESENT 3 0.0002
592 FEELING JITTERY 3 0.0002
593 JOINT SWELLING 19 0.0002
594 SLEEP APNOEA SYNDROME 3 0.0002
595 CYSTITIS 5 0.0002
596 LOWER LIMB FRACTURE 3 0.0002
597 ACUTE RESPIRATORY FAILURE 3 0.0002
598 DRUG INTOLERANCE 15 0.0002
599 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
600 INFUSION SITE PAIN 2 0.0002
601 HERNIA 3 0.0002
602 CARDIAC FLUTTER 1 0.0002
603 APPLICATION SITE VESICLES 1 0.0002
604 SOMNOLENCE 31 0.0002
605 RESPIRATORY TRACT INFECTION 4 0.0002
606 BRADYPHRENIA 1 0.0002
607 DEAFNESS 4 0.0002
608 IMPAIRED HEALING 5 0.0002
609 CONSTIPATION 33 0.0002
610 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
611 ABDOMINAL PAIN UPPER 31 0.0002
612 BLOOD PRESSURE DECREASED 10 0.0002
613 LIP SWELLING 5 0.0001
614 SKIN DISORDER 5 0.0001
615 AGITATION 11 0.0001
616 SPINAL FRACTURE 3 0.0001
617 BREAST MASS 1 0.0001
618 FEAR 4 0.0001
619 PAIN OF SKIN 4 0.0001
620 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
621 CROHN'S DISEASE 1 0.0001
622 DIVERTICULITIS 4 0.0001
623 FALL 48 0.0001
624 ARTHROPATHY 8 0.0001
625 ORAL DISCOMFORT 2 0.0001
626 HYPOMAGNESAEMIA 2 0.0001
627 APHONIA 2 0.0001
628 HEART RATE INCREASED 14 0.0001
629 FLATULENCE 8 0.0001
630 IRRITABLE BOWEL SYNDROME 3 0.0001
631 PARALYSIS 2 0.0001
632 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
633 CARDIOGENIC SHOCK 2 0.0001
634 IMPAIRED QUALITY OF LIFE 2 0.0001
635 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
636 INJECTION SITE HAEMATOMA 2 0.0001
637 PRODUCT DISPENSING ERROR 3 0.0001
638 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
639 CRYING 5 0.0001
640 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
641 SURGERY 8 0.0001
642 CARDIOMYOPATHY 2 0.0001
643 BRONCHITIS 10 0.0001
644 CONTUSION 13 0.0001
645 HYPOTENSION 27 0.0001
646 RASH PAPULAR 3 0.0001
647 HAEMORRHAGE INTRACRANIAL 2 0.0001
648 RESPIRATORY DISORDER 4 0.0001
649 CHROMATURIA 3 0.0001
650 APHASIA 4 0.0001
651 DEVICE FAILURE 2 0.0001
652 DIABETES MELLITUS 10 0.0001
653 ADVERSE EVENT 12 0.0001
654 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
655 THYROID DISORDER 2 0.0001
656 APHTHOUS ULCER 1 0.0001
657 COUGH 36 0.0001
658 AFFECTIVE DISORDER 1 0.0001
659 TREMOR 21 0.0001
660 RASH 55 0.0001
661 MEDICATION ERROR 7 0.0001
662 MIGRAINE 12 0.0001
663 PRODUCTIVE COUGH 6 0.0001
664 ATRIAL FLUTTER 1 0.0001
665 BLISTER 7 0.0001
666 MENTAL IMPAIRMENT 3 0.0001
667 ATRIAL FIBRILLATION 12 0.0001
668 BACK DISORDER 2 0.0001
669 ASPHYXIA 1 0.0001
670 INJECTION SITE URTICARIA 3 0.0001
671 DRUG LEVEL INCREASED 2 0.0001
672 BREAST CANCER STAGE II 1 0.0001
673 FUNGAL INFECTION 4 0.0001
674 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
675 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
676 WEIGHT DECREASED 33 0.0001
677 RENAL FAILURE ACUTE 5 0.0001
678 CARDIAC DISORDER 11 0.0001
679 SCAR 2 0.0001
680 MUSCULOSKELETAL DISCOMFORT 2 0.0001
681 ANURIA 1 0.0001
682 SKIN ULCER 3 0.0001
683 CARDIAC MURMUR 1 0.0001
684 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
685 OEDEMA PERIPHERAL 14 0.0001
686 MUSCLE SPASMS 21 0.0001
687 RASH MACULAR 4 0.0001
688 SYRINGE ISSUE 2 0.0001
689 HYPOAESTHESIA 17 0.0001
690 SLEEP DISORDER 8 0.0001
691 ABDOMINAL DISCOMFORT 19 0.0001
692 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
693 INSOMNIA 30 0.0001
694 DEHYDRATION 15 0.0001
695 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
696 BREAST CANCER FEMALE 3 0.0001
697 DECREASED APPETITE 26 0.0001
698 THIRST 2 0.0001
699 GOUT 2 0.0001
700 ANAL INCONTINENCE 1 0.0001
701 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
702 SYNOVITIS 2 0.0001
703 BONE DISORDER 2 0.0001
704 PANIC ATTACK 4 0.0001
705 GAIT DISTURBANCE 21 0.0001
706 DYSPNOEA 62 0.0001
707 RESPIRATORY DISTRESS 3 0.0001
708 DYSURIA 4 0.0001
709 HYPERTENSION 23 0.0001
710 FEELING COLD 3 0.0001
711 BACK PAIN 25 0.0001
712 AMNESIA 7 0.0001
713 SEPSIS 12 0.0001
714 HAEMOPTYSIS 3 0.0001
715 THINKING ABNORMAL 2 0.0001
716 APPENDICITIS 1 0.0001
717 DEFORMITY 1 0.0001
718 ILLNESS 11 0.0001
719 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
720 ASTHENIA 40 0.0001
721 DYSARTHRIA 4 0.0001
722 HOT FLUSH 8 0.0001
723 GASTRIC ULCER 2 0.0001
724 ANGINA PECTORIS 3 0.0001
725 HYPERSOMNIA 3 0.0001
726 RASH ERYTHEMATOUS 5 0.0001
727 AFFECT LABILITY 1 0.0001
728 ERUCTATION 2 0.0001
729 DYSTONIA 2 0.0001
730 AUTOIMMUNE DISORDER 1 0.0001
731 HAEMORRHOIDS 2 0.0001
732 ORAL HERPES 2 0.0001
733 LUNG DISORDER 5 0.0001
734 CONDITION AGGRAVATED 31 0.0001
735 DISABILITY 2 0.0001
736 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
737 BLOOD PRESSURE ABNORMAL 2 0.0001
738 NAUSEA 79 0.0001
739 CORONARY ARTERY DISEASE 3 0.0001
740 ABDOMINAL PAIN 23 0.0001
741 PSORIATIC ARTHROPATHY 4 0.0001
742 DISCOMFORT 6 0.0001
743 FLUID RETENTION 5 0.0001
744 THERAPY INTERRUPTED 7 0.0001
745 FEELING HOT 6 0.0001
746 THERAPY CESSATION 5 0.0001
747 MUSCULAR WEAKNESS 11 0.0001
748 INTENTIONAL DRUG MISUSE 2 0.0001
749 ECZEMA 5 0.0001
750 DERMATITIS 2 0.0001
751 DERMATITIS ATOPIC 5 0.0001
752 NEUROPATHY PERIPHERAL 9 0.0001
753 DEPRESSED MOOD 5 0.0001
754 DIARRHOEA 61 0.0001
755 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
756 MALAISE 41 0.0001
757 SKIN CANCER 2 0.0001
758 DRUG EFFECT DECREASED 5 0.0001
759 DISTURBANCE IN ATTENTION 5 0.0001
760 DECREASED ACTIVITY 1 0.0001
761 FAECES DISCOLOURED 2 0.0001
762 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
763 CHOLELITHIASIS 3 0.0001
764 ARTHRALGIA 38 0.0001
765 PRODUCT STORAGE ERROR 8 0.0001
766 PRODUCT USE ISSUE 17 0.0001
767 STEVENS-JOHNSON SYNDROME 2 0.0001
768 URINARY RETENTION 3 0.0001
769 GAIT INABILITY 3 0.0001
770 PNEUMONIA 29 0.0001
771 GLOSSODYNIA 2 0.0001
772 PULMONARY OEDEMA 4 0.0001
773 TYPE 2 DIABETES MELLITUS 3 0.0001
774 BLOOD CALCIUM DECREASED 1 0.0001
775 ASTHMA 10 0.0001
776 MYALGIA 15 0.0001
777 APPLICATION SITE PRURITUS 2 0.0001
778 PAIN 54 0.0001
779 DEPRESSION 20 0.0001
780 NEPHROLITHIASIS 4 0.0001
781 HERPES ZOSTER 5 0.0001
782 LETHARGY 5 0.0001
783 NASOPHARYNGITIS 16 0.0001
784 HYPOKALAEMIA 4 0.0001
785 CONFUSIONAL STATE 14 0.0001
786 DELIRIUM 3 0.0001
787 BLOOD CHOLESTEROL INCREASED 4 0.0001
788 HEART RATE DECREASED 3 0.0001
789 CHILLS 10 0.0001
790 HYPOXIA 3 0.0001
791 INFLUENZA LIKE ILLNESS 7 0.0001
792 CARDIAC ARREST 7 0.0001
793 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
794 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
795 WHEEZING 5 0.0001
796 BLOOD IRON DECREASED 1 0.0001
797 ATAXIA 1 0.0001
798 PRODUCT ADHESION ISSUE 3 0.0001
799 BLOOD PRESSURE FLUCTUATION 2 0.0001
800 INFECTION 12 0.0001
801 DRUG EFFECT INCOMPLETE 3 0.0001
802 STOMATITIS 5 0.0001
803 BURSITIS 1 0.0001
804 UNDERDOSE 6 0.0001
805 ACCIDENTAL OVERDOSE 3 0.0001
806 CARDIOMEGALY 1 0.0001
807 CHEST PAIN 15 0.0001
808 ABASIA 2 0.0001
809 MEMORY IMPAIRMENT 11 0.0001
810 MUSCULOSKELETAL STIFFNESS 7 0.0001
811 CELLULITIS 4 0.0001
812 BRAIN OEDEMA 1 0.0001
813 PRODUCT COMPLAINT 2 0.0001
814 URTICARIA 13 0.0001
815 NO ADVERSE EVENT 14 0.0001
816 HAEMATOMA 2 0.0001
817 PLASMA CELL MYELOMA 3 0.0001
818 CEREBROVASCULAR ACCIDENT 13 0.0001
819 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
820 NERVOUSNESS 4 0.0001
821 ALOPECIA 15 0.0001
822 MUSCULOSKELETAL PAIN 4 0.0001
823 APPLICATION SITE ERYTHEMA 2 0.0001
824 PARAESTHESIA 12 0.0001
825 JOINT STIFFNESS 2 0.0001
826 DISEASE PROGRESSION 9 0.0001
827 ANKYLOSING SPONDYLITIS 1 0.0001
828 ABNORMAL BEHAVIOUR 3 0.0001
829 FEBRILE NEUTROPENIA 5 0.0001
830 NEOPLASM MALIGNANT 5 0.0001
831 PRODUCT DOSE OMISSION ISSUE 22 0.0001
832 CARDIAC FAILURE CONGESTIVE 6 0.0001
833 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
834 BLOOD GLUCOSE INCREASED 14 0.0001
835 DYSKINESIA 3 0.0001
836 NEUTROPHIL COUNT DECREASED 3 0.0001
837 FATIGUE 57 0.0001
838 LUNG NEOPLASM MALIGNANT 3 0.0001
839 ANAPHYLACTIC REACTION 4 0.0001
840 MENTAL STATUS CHANGES 2 0.0001
841 RHABDOMYOLYSIS 3 0.0001
842 POLLAKIURIA 3 0.0001
843 WOUND 2 0.0001
844 TOXICITY TO VARIOUS AGENTS 12 0.0001
845 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
846 INTENTIONAL DOSE OMISSION 2 0.0001
847 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
848 BRONCHOSPASM 1 0.0001
849 SYNCOPE 7 0.0001
850 HYPERHIDROSIS 9 0.0001
851 MOBILITY DECREASED 5 0.0001
852 PRODUCT SUBSTITUTION ISSUE 4 0.0001
853 DRUG INTERACTION 11 0.0001
854 PANCREATIC CARCINOMA 2 0.0001
855 ANOSMIA 1 0.0001
856 LIVER FUNCTION TEST ABNORMAL 2 0.0001
857 OFF LABEL USE 60 0.0001
858 COVID-19 12 0.0001
859 HAEMOGLOBIN DECREASED 7 0.0001
860 LIVER DISORDER 3 0.0001
861 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
862 THERAPY NON-RESPONDER 3 0.0001
863 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
864 BLOOD COUNT ABNORMAL 1 0.0001
865 INJECTION SITE RASH 2 0.0001
866 LIMB DISCOMFORT 2 0.0001
867 COGNITIVE DISORDER 3 0.0001
868 SWELLING 6 0.0001
869 SWOLLEN TONGUE 2 0.0001
870 BRAIN FOG 1 0.0001
871 ARRHYTHMIA 3 0.0001
872 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
873 MYOCARDIAL INFARCTION 11 0.0001
874 INJECTION SITE BRUISING 5 0.0001
875 HYPOTHYROIDISM 2 0.0001
876 METABOLIC ACIDOSIS 2 0.0001
877 WEIGHT INCREASED 14 0.0001
878 HIP FRACTURE 2 0.0001
879 THROMBOSIS 5 0.0001
880 NIGHT SWEATS 2 0.0001
881 VOMITING 29 0.0001
882 RHEUMATOID ARTHRITIS 7 0.0001
883 BLOOD POTASSIUM INCREASED 1 0.0001
884 BLOOD CREATININE INCREASED 4 0.0001
885 PYREXIA 21 0.0001
886 STAPHYLOCOCCAL INFECTION 2 0.0001
887 DRUG DOSE OMISSION 10 0.0001
888 DEVICE DIFFICULT TO USE 4 0.0001
889 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
890 VIRAL INFECTION 2 0.0001
891 COAGULOPATHY 1 0.0001
892 ANXIETY 17 0.0001
893 BLOOD UREA INCREASED 1 0.0001
894 RENAL IMPAIRMENT 5 0.0001
895 CANDIDA INFECTION 1 0.0001
896 DEATH 51 0.0001
897 ANGER 2 0.0001
898 HAEMATURIA 2 0.0001
899 GASTRIC DISORDER 2 0.0001
900 INJECTION SITE REACTION 4 0.0001
901 INFLAMMATION 3 0.0001
902 ANAEMIA 11 0.0001
903 SPEECH DISORDER 3 0.0001
904 INTENTIONAL PRODUCT MISUSE 5 0.0001
905 COLD SWEAT 1 0.0001
906 BRADYCARDIA 3 0.0001
907 LYMPHADENOPATHY 2 0.0001
908 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
909 CEREBRAL HAEMORRHAGE 2 0.0001
910 OEDEMA 3 0.0001
911 TREATMENT NONCOMPLIANCE 3 0.0001
912 LOSS OF CONSCIOUSNESS 7 0.0001
913 PANCYTOPENIA 3 0.0001
914 THROMBOCYTOPENIA 6 0.0001
915 OXYGEN SATURATION DECREASED 3 0.0001
916 HYPONATRAEMIA 3 0.0001
917 BLOOD SODIUM DECREASED 1 0.0001
918 UNEVALUABLE EVENT 4 0.0001
919 ACNE 4 0.0001
920 RENAL FAILURE 7 0.0001
921 DYSPHAGIA 5 0.0001
922 CHOKING 1 0.0001
923 DISORIENTATION 2 0.0001
924 ILL-DEFINED DISORDER 3 0.0000
925 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
926 INJECTION SITE ERYTHEMA 6 0.0000
927 CARDIO-RESPIRATORY ARREST 2 0.0000
928 ROAD TRAFFIC ACCIDENT 2 0.0000
929 VAGINAL HAEMORRHAGE 2 0.0000
930 DEVICE DISLOCATION 2 0.0000
931 SEPTIC SHOCK 2 0.0000
932 PRODUCT DOSE OMISSION 3 0.0000
933 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
934 INFLUENZA 5 0.0000
935 GASTROINTESTINAL DISORDER 4 0.0000
936 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
937 SEIZURE 5 0.0000
938 PULMONARY EMBOLISM 4 0.0000
939 COMA 2 0.0000
940 BLOOD GLUCOSE DECREASED 2 0.0000
941 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
942 HYPOGLYCAEMIA 2 0.0000
943 RESPIRATORY FAILURE 3 0.0000
944 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
945 LEUKOPENIA 2 0.0000
946 AGGRESSION 2 0.0000
947 HALLUCINATION 3 0.0000
948 FLUSHING 4 0.0000
949 INJECTION SITE SWELLING 3 0.0000
950 ANAPHYLACTIC SHOCK 1 0.0000
951 PSORIASIS 5 0.0000
952 HAEMORRHAGE 4 0.0000
953 INJECTION SITE HAEMORRHAGE 3 0.0000
954 CARDIAC FAILURE 3 0.0000
955 PROSTATE CANCER 3 0.0000
956 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
957 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
958 ABNORMAL DREAMS 1 0.0000
959 TREATMENT FAILURE 3 0.0000
960 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
961 CONVULSION 2 0.0000
962 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
963 ASCITES 1 0.0000
964 ACUTE MYOCARDIAL INFARCTION 1 0.0000
965 BLOOD POTASSIUM DECREASED 1 0.0000
966 PLEURAL EFFUSION 2 0.0000
967 SUICIDAL IDEATION 3 0.0000
968 HOSPITALISATION 5 0.0000
969 BONE DENSITY DECREASED 1 0.0000
970 INTENTIONAL OVERDOSE 2 0.0000
971 DEEP VEIN THROMBOSIS 2 0.0000
972 INJECTION SITE PRURITUS 2 0.0000
973 INJECTION SITE PAIN 9 0.0000
974 DEVICE MALFUNCTION 2 0.0000
975 INJURY 2 0.0000
976 PLATELET COUNT DECREASED 3 0.0000
977 C-REACTIVE PROTEIN INCREASED 1 0.0000
978 COLITIS 1 0.0000
979 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
980 EMOTIONAL DISTRESS 3 0.0000
981 DEVICE BREAKAGE 1 0.0000
982 OVERDOSE 5 0.0000
983 ANGIOEDEMA 1 0.0000
984 TACHYCARDIA 2 0.0000
985 COLITIS ULCERATIVE 1 0.0000
986 DEVICE ISSUE 2 0.0000
987 BREAST CANCER 2 0.0000
988 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
989 DRUG DEPENDENCE 3 0.0000
990 ACUTE KIDNEY INJURY 2 0.0000